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ABSTRACT 
Objective: The present study was aimed to develop metronidazole (MNZ) loaded poly lactic-co-glycolic acid (PLGA) based mucoadhesive 
nanoparticles (NPs) in prolonged treatment in periodontitis. 
Methods: Nanoparticles were prepared by using single (SE) and double (DE) emulsion method to determine the suitability of methods. Prepared 
NPs were evaluated for surface morpholgy, mean particle size, polydispersity index, zeta potential, mucoadhesion ability and invitro-drug release, 
Results: SEM images confirmed that NPs were of spherical shape and smooth surface. Mean particle size, of MNZ loaded NPs were found 
583.28±18.22 and 872.72±63.18 prepared by SE and DE method. Similarly, polidispersity index (0.68±0.1 and 0.83±0.06) and zeta potention (-
33.29±0.7 and-31.28.0.6) was found in acceptable range. Prepared NPs were surface treated with Sodium alginate (SA) to increase mucoadhesive 
property. It was observe that particles remain adhere till 24 hr with biological membrane. Prepared NPs allow release of MNZ upto 24 h in 
sustained manner. 
Conclusion: This study confirms that the prepared MNZ loaded NPs may be used as an better alternate with addition application such as prolonged 
action thus improved patient compliance. 
Keywords: Metronidazole, Nanoparticles, Periodontitis  




Natural or synthetic polymers have wide applications by making 
system bioadhesive or mucoadhesive thereby extending the 
retention time. This concept of prolonged retention can be utilized 
for drug delivery systems for localized periodontal therapy by 
retention on the mucosal surface and controlled drug release at the 
site of action. The prospects of bioadhesion encompass prolonged 
drug delivery, localized therapy, targeting of specific tissues and a 
close contact with the substrate [1, 2]. 
Oral Cavity is an assessable site for deploying devices. Buccal tissues 
and periodontium are the potential sites for localized and topical 
drug delivery. The common oral lesions such as aphthous ulceration 
can be treated via buccal cavity and the periodontium, where 
destructive periodontal diseases might benefit from improved 
therapeutics. So, several studies have recently suggested that 
mucoadhesive polymers might be useful for periodontal pocket 
therapy for longer retention of formulation at its desire site [3, 4].  
As discussed above, bioadhesive or mucoadhesive polymers can 
prolong the retention at the mucosal surface by providing intimate 
contact between the dosage form and absorbing tissues in the 
periodontal pocket. Therefore, bioadhesive and biodegradable 
nanoparticles with controlled release characteristics, withdraws the 
attention of various researchers in the developmental phase of long-
retentive drug delivery systems.  
In addition to bioadhesivity, controlling the release of a drug from 
the dosage form is also desirable. Controlled rate of drug delivery 
provides a persistent delivery of drugs at anticipating and 
reproducible kinetics for a predetermined period. The prospectives 
of this concept is the minimization of drug related side effects (due 
to controlled therapeutic blood levels instead of oscillating blood 
levels) and improved patient compliance (due to reduced frequency 
of dosing). Furthermore, if system is biodegradable, sustained-
release, then it can be placed into the periodontal pocket to maintain 
therapeutic concentration for prolonged periods and patients will 
not required to revisit the dentist to have these devices removed at 
the completion of therapy thereby making them cost effective.  
Among the imidazole derivatives, MNZ is one compound with potent 
antiprotozoal activity against E. Hystolytica, T. vaginalis and giardia 
including periodontal pathogens [5]. Due to its short half-life, it 
requires frequent dosing. Therefore, objective of the present study 
was to develop biodegrable mucoadhesive nanocarrier system 
containing MTZ for sustained release of the drug in periodontal 
pocket and cover the most of the microorganisms present in deep 
pocket. 
MATERIALS AND METHODS 
Materials  
MNZ was kindly gifted as sample from Plethico Pharmaceutical Pvt. 
Ltd, Indore, India. Poly Lactic Glycolic Acid (PLGA, 50:50) and 
sodium alginate (SA) was purchased from Sigma Aldrich (St. Louis, 
MO). The other ingredients used were of analytical grade and 
purchased from Central Drug Laboratory, New Delhi, India and 
Sigma Aldrich (St. Louis, MO). 
Fourier transform infrared spectroscopy (FT-IR) 
In order to determine chemical incompatibility between drug and 
polymer, FTIR absorption spectra were taken using FT-IT 
spectrophotometer (Jasco, Eastern, Maryland, Japan). Samples were 
mixed with potassium bromide (KBr) in equimolar quantity, 
punched and then spectra were obtained using the analyzer. FTIR 
spectra of MNZ, SA, PLGA and physical mixture were scanned in the 
range of 4000-400 cm−1
Preparation of nanoparticles (NPs) 
. 
The MNZ loaded NPs were prepared by emulsion-solvent 
evaporation method. In order to determined the suitability of 
method two different processes was used. These methods are 
discussed here 
Single emulsion (SE) method  
This method was used as per previous literature by with slight 
modification [6]. Briefly, PLGA (2% w/v) was accurately weighed 
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and dissolved in 5 ml of acetone as organic solvent containing MNZ 
(drug and polymer ratio 1:10). Similarly aqueous phase was 
prepared by dissolving polyvinyl alcohol (PVA, 1% w/v) as stabilizer 
in distilled water. Organic phase was slowly dispersed into the 
aqueous phase and stirred magnetically (REMI, Mumbai, India) 
(1800 rpm) to form o/w emulsion. The prepared emulsion was 
converted into nano-droplets by subjecting to high pressure 
homogenization. The resulting nano-emulsion was left agitated at 
700 rpm with a magnetic stirrer for next 2 to 4 h to remove organic 
solvent. The turbid nanosuspension thus obtained is centrifuged 
(REMI, Mumbai, India) at 18000 rpm for 30 min and washed twice 
with water and then freeze dried (Heto DRYWINNER, Germany) to 
obtain MNZ loaded PLGA NPs. 
Double emulsification (DE) Method 
This method was used as per the previous reports of Vandervoort 
and Ludwig, 2002; Song et al., 2008 with slight modifications [7,8]. 
Aqueous PVA solution was dispersed into organic phase (5 ml) 
contains PLGA and drug (10:1) dissolved in acetone under magnetic 
stirring (REMI, Mumbai, India) at 1800 rpm. This primary emulsion 
was dispersed in outer aqueous stabilizer solution (10 ml) and 
subjecting to homogenization. The resulting double emulsion 
(w/o/w) was further diluted and left agitated (700 rpm) with a 
magnetic stirrer for next 2 to 4 h to remove organic solvent. 
Consequently, the MNZ loaded NPs were isolated by cooling 




The surface morphology and geometrical size of prepared MNZ 
loaded NPs were determined using scanning electron microscope 
EVO18 research, ZEISS). Drug loaded NPs (prepared by both 
methods) were dusted on double sided tape on an aluminium stub 
and coated with gold using a cold sputter coater to a thickness of 
300Å. Images of NPs were captured using 20 kv electron beam. 
Mean particle size (MPs), polydispersity index (PI) and zeta 
potential 
Mean particle size (MPS) and polydispersity index (PI) was 
measured using light scattering diffraction method (Zetasizernano 
ZS, Malvern instruments Inc, Southborough, MA). Typically, a sample 
was placed in a cuvette and the measurements were done at 25 °C 
after dispersing the NPs into suitable media. Similarly, Zeta potential 
was measured with a disposable capillary cell with a volume of 1 ml. 
The mean value was determined using a mono-modal distribution. 
Each analysis was performed in triplicate. 
Drug loading and entrapment efficiency  
Drug loading and percentage entrapment efficiency of prepared 
MNZ loaded NPs was determined using method reported by Stolnik 
et al. 1998 [9]. Free drug in the supernatant of NPz suspension was 
separated by centrifugation of NPs suspension at 18000 rpm for 1 h. 
The supernatant was removed and nanoparticles sediments were 
washed twice with distilled water in order to remove the MNZ from 
the surface of NPs. Drug content in the supernatant was calculating 
by using UV-visible spectrophotometer (UV-1601, Shamdzu Co. Ltd. 
Japan). The nanoparticles obtained were dried using freeze dryer. 
Drug loading (DL) was then determined using the following equation:  
 
Similarly, the entrapment efficiencies (EE) of NPs were determined 
with the percent ratio of the actual amount of drug incorporated into 
NPs to the total amounts of drug used. The equation is as follow:  
 
Coating of drug loaded PLGA NPs  
The objective of the present study is to prepared mucoadhesive 
NPs to improve the retention of delivery system into dental cavity 
for longer duration of time. The presence of mucoadhesive 
polymer on the surface of PLGA NPs can modulate the interfacial 
property of the carrier and hence can positively influence the 
application potentialities both in terms of mucoadhesion and 
improved drug permeation. For this reason we investigated the 
possibility of coating the surface of MNZ loaded NPs with sodium 
alginate as mucoadhesive polymers by simple adsorption process 
[6]. The freeze dried PLGA nanoparticles were suspended in 
sodium alginate solution (1% w/v) for 24 h. The coated particles 
were then collected after centrifugation, washing and freeze 
drying. 
Mucoadhesion study 
To determine the mucoadhesion ability of prepared NPs the 
method was used described in the literature of Sharma et al., 2013 
with slight modification [10]. The MNZ loaded NPs (both batch) 
were dispersed in a 10 ml glass tube at containing phosphate 
buffer solution (pH 7.4) at 37±0.5̊ C for 5 min in such a way that 
surface of all the NPs covered by the media. NPs (2.5 mg) were 
transferred on the glass slide which was previously mounted by 
freshly excised pieces of goat intestinal mucosa (2×2 cm) 
(collected from slaughter house) and left for 30 min in desiccators 
to facilitate the interaction between NPs and mucosa. The 
membrane with the attached NPs was removed after 12 and 24 h. 
Remaining NPs on the glass beaker were dried at 60̊C till constant 
weight. The percent of adhered nanoparticles (AN) was estimated 
using the following equation:  
 
In vitro drug release studies of NPs 
Release of MNZ from the prepared NPs (coated and uncoated NPs 
from SE and DE) was estimated using dialysis method [10]. Briefly, 
required quantity of NPs (equivalent to single dose of MNZ)) was 
transferred into phosphate buffer (pH 6.8) as dissolution media 
(containing 0.5% (w/w) Tween 80 as solubilizer). The rotational 
speed was set to 100 rpm, and the temperature was set to 37±0.05 
◦C. At predetermined time schedule, release medium (1 ml) was 
replaced with the equal quantity of fresh media. Concentration of 
released MNZ from the NPs was measured with UV 
spectrophotometer (UV-1601, Shamdzu Co. Ltd. Japan) at 288 nm. 
All experiments were in triplicate and the results were represented 
in±SD. 
RESULTS AND DISCUSSION 
FT-IR spectra 
For the determination of possibility of chemical integration, FT-IR 
spectra of pure MNZ, SA, PLGA and physical mixture was obtained 
(fig. 1). Spectra of MNZ (fig. 1a) showed O-H stretching at 3239.47 
cm-1 and C-H stretching at 3102.38 cm-1. Peak at 3017.29 and 
1542.39 cm-1was due to asymmetric–CH2 and asymmetric NO2 
group [11]. FT-IR spectra of PLGA showed presence of–CH,–CH2,–
CH3 stretching (2850-3000 cm-1), carbonyl stretching (1700-1800 
cm-1), and C-O stretching (1050-1250 cm-1). The obtained FT-IR 
spectrum indicates that all characteristic peaks of MNZ were 
present in the spectrum of physical mixture, which indicates no 
significant physical or chemical interaction between MNZ and 
polymers. 
Preparation of NPs 
MNZ loaded NPs were prepared using single and double 
emulsification solvent evaporation methods. During emulsification 
method a native emulsion is formed due to dispersion of an organic 
phase into aqueous phase. This emulsion was stabilized using 
surfactant and stabilizers. Prepared NPs were characterized for 
various parameters 
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Fig. 1: FTIR spectra of (A) MNZ (B) SA (C) PLGA and (D) physical mixture 
 
Characterization of NPs 
Particle size and zeta potential 
Particle size of prepared MNZ loaded NPs and empty NPs were 
determined using light scattering method and obtained results are 
summerized in table 1. Results indicates that empty NPs were in the 
nanometric range showing mean diameter 385±13.94 nm with SE 
and 792.72±55.92 nm with DE and exhibited a narrow size 
distribution. MNZ loaded particles exhibited mean particle size 
583.28±18.22 and 872.72±63 nm prepared by SE and DE, 
respectively. Result indicates that drug loaded NPs was bigger than 
empty NPs. Results also demonstrated that NPs prepared by DE 
method were significantly large (p<0.01) compare to those 
produced by SE method. This could be explained on the basis of the 
fact that in single emulsification method internal aqueous 
compartment is absent, only two immiscible liquid phases (AC phase 
in aqueous buffer external phase) are present. As we have 
mentioned earlier, the AC organic phase has low viscosity, so shear 
(mechanical work) required for emulsification process was not as 
much of DE. In DE method, primary emulsion need to be dispersed in 
external buffer phase and the viscosity of primary emulsion is 
enough high and required high shears for emulsification. So in 
identical formulation and process parameters, NPs produced by DE 
are bigger (p<0.01) compare to SE [12, 13]. 
Particle size distribution of prepared NPs was determined using PI 
determination. Obtained data of PI are also given in table 1 and fig. 2. 
Vales are showing relatively narrow size distribution in NPs 
prepared by SE and DE method.  
Result of ZP are given in table 1 indicate that both empty and drug-
loaded NPs prepared by SE and DE exhibited negative charge with 
values ranging from-27.19±0.4 to-33.29±0.7 Mv. The negative 
surface charge of PLGA NPs can be attributed due to the presence of 
carboxyl groups of the polymer on the nanoparticles surface, as 
reported previously for drug free PLGA-NPs [8]. Results of ZP also 
indicate slight increments in negative surface value with drug 
loading. 
Surface morphology 
Surface morphology of prepared NPs were observed using SEM. 
Obtained SEM images are given in fig. 3. Images indicate that the 
prepared NPs were of spherical shape with a smooth surface. No 
difference was observed in the morphological properties of 
nanoparticles due to presence of the drug. 
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Fig. 2: Particle size distribution graph for empty PLGA-NPs prepared by SE (a) MNZ loaded PLGA-NPs prepared by SE (b) empty PLGA-NPs 
prepared by DE (c) MNZ loaded PLGA-NPs prepared by DE (d) 
 
Table 1: MPS, PI and zeta potential of PLGA empty and drug loaded nanoparticles prepared by SE and DE 
Parameter Single emulsification Double emulsification 
Empty-NPs MNZ loaded-NPs Empty-NPs MNZ loaded-NPs 
MPS (nm)  385±13.94 583.28±18.22** 792.72±55.92 872.72±63.18 
PI 0.62±0.05 0.88±0.1 0.74±0.007 0.83±0.06 
Zeta potential (mV) -27.19±0.4 -33.29±0.7 -28.39±0.5 -31.28±0.6 
Data are shown as the mean±SD. (n=3); **
 
p<0.01 compared with DE method 
 
Fig. 3: Microphotographs of empty PLGA-NPs prepared by SE (a) MNZ loaded PLGA-NPs prepared by SE (b) empty PLGA-NPs prepared by 
DE (c) MNZ loaded PLGA-NPs prepared by DE (d) 
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Drug loading and entrapment efficiency 
Drug loading and entrapment efficiency of NPs prepared by SE and 
DE methods was determined and obtained data are depicted in fig. 4. 
Data showed that drug loading and entrapment efficiency was 
reduced significantly (p<0.001) from 7.3±0.07 % to 6.1±0.02 and 
73.29±0.37 to 61.28±2.18 when NPs were prepared using SE and DE 
method respectively which may be due to highly viscous droplets 
during the preparation of single emulsion method. Highly viscous 
droplets prevent the migration of drug to the surrounding media 
[14, 15]. Data suggest that single emulsification method was found 
suitable for the preparation of drug loaded PLGA Nanoparticles. 
 
 




Mucoadhesion ability of SA coated NPs prepared by SE and DE 
method was determined and obtained data are depicted in fig. 5. 
Data indicates that NPs prepared by SE method possess better 
adhesion (57.82±8.48 %) with biological membrane as compared to 
NPs prepared by DE (32.46±9.37 %). Better bioadhesion of NPs 
prepared by SE can be attributed by the smaller particle size 
compare to the NPs prepared by DE. Smaller particles of NPs (SE) 
exhibit comparative higher available surface area for mucoadhesion. 
The mucoadhesive strength of NPs was determined for 1 d and it 
was found that as the duration increase the mucoadhesive strength 
decreases and after 24 h it was found to be only 29.04±8.64 and 
18.27±3.88 % for NPs prepared by SE and DE. 
  
 
Fig. 5: Percentage adherent nanoparticles (prepared by SE and DE method) at 12 and 24 h, data are presented as mean±SD (n=3) 
 
Drug release 
Percentage release of MNZ from coated and uncoated NPs was 
estimated by dialysis method. Obtained data are depicted in fig. 
6. Data revealed that all NPs except SA coated NPs prepared by 
DE method allowed MNZ release within 24 h time course study. 
Only, 95.38±8.37 percentage MNZ was release from the SA 
uncoated NPs prepared by DE method. This was observed NPs 
prepared by SE method allow rapid release of MNZ compared to 
NPs prepared by DE method. This result may be correlated with 
the size of prepared NPs. Since Lower size NPs prepared by SE 
method possess larger surface are for drug release compared to 
the NPs prepared by DE method [16]. It was also observed that 
coating of SA on any type of NPS retard the drug release. This 
may be due to the formation of three dimensional structure of SA 
after hydration. Now the released drug from the NPs has to be 
crossed this barrier of SA for its complete migration into 
dissolution media. 
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Fig. 6: Percentage release of MNZ upto 24 h from SA-coated* and SA-uncoated#
 
 NPs prepared by SE and DE method. Data are presented as 
mean±SD (n=3) 
CONCLUSION 
The study was successful in order to develop a MNZ loaded NPs for 
sustain delivery upto 24 h. Single emulsification solvent evaporation 
method was found suitable for the preparation of MNZ loaded NPs. 
Obtained data of particle size, zeta potential, drug loading, 
mucoadhsion and in vitro drug release confirmed the suitability of 
prepared NPs for successful delivery of MNZ in periodontitis upto 24 
h. Further, few study such safety and efficacy study of NPs in in vivo 
animal or human model may also be conduct for complete 
establishment of delivery system.  
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